Chemoinformaics analysis of Ulexone C
Molecular Weight | 420.461 | nRot | 2 |
Heavy Atom Molecular Weight | 396.269 | nRig | 27 |
Exact Molecular Weight | 420.157 | nRing | 5 |
Solubility: LogS | -2.822 | nHRing | 3 |
Solubility: LogP | 5.081 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 62.565 |
nHD | 2 | BPOL | 30.153 |
QED | 0.638 |
Synth | 3.762 |
Natural Product Likeliness | 2.656 |
NR-PPAR-gamma | 0.974 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.956 |
Pgp-sub | 0.001 |
HIA | 0.031 |
CACO-2 | -4.666 |
MDCK | 0.0000178 |
BBB | 0.018 |
PPB | 0.980967 |
VDSS | 0.501 |
FU | 0.0211697 |
CYP1A2-inh | 0.412 |
CYP1A2-sub | 0.472 |
CYP2c19-inh | 0.478 |
CYP2c19-sub | 0.07 |
CYP2c9-inh | 0.775 |
CYP2c9-sub | 0.893 |
CYP2d6-inh | 0.54 |
CYP2d6-sub | 0.362 |
CYP3a4-inh | 0.416 |
CYP3a4-sub | 0.308 |
CL | 2.898 |
T12 | 0.206 |
hERG | 0.051 |
Ames | 0.021 |
ROA | 0.648 |
SkinSen | 0.283 |
Carcinogencity | 0.849 |
EI | 0.013 |
Respiratory | 0.521 |
NR-Aromatase | 0.908 |
Antiviral | Yes |
Prediction | 0.715849 |